Biologic Exclusivity Provision In USMCA Is Boon To Generics Industry; BIO Is 'Tremendously Worried'

 
• By Brenda Sandburg
Washington, DC - January 2019: USMCA United States Mexico Canada Agreement Treaty. Political Contract And Deal By Donald Trump - 2d Illustration
Deal revising the USMCA strips biologics exclusivty provision and other pharma IP requirements

More from Legal & IP

More from Pink Sheet